Severe menorrhagia associated with thrombocytopenia

Obstetrics and Gynecology

Volumn 110, Issue 4, 2007, Pages 913-917

  Levens, Eric D ^a,b   Scheinberg, Phillip ^c   DeCherney, Alan H ^b  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; ESTROGEN; ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS NORELGESTROMIN; ETHINYLESTRADIOL PLUS NORETHISTERONE; GESTAGEN; LEUPRORELIN; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE; ORAL CONTRACEPTIVE AGENT;

APLASTIC ANEMIA; ARTICLE; BLOOD TRANSFUSION; BONE MARROW SUPPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG MEGADOSE; FOLLOW UP; HOT FLUSH; HUMAN; HYSTERECTOMY; INCIDENCE; LOW DRUG DOSE; MENORRHAGIA; MOOD CHANGE; OSTEOLYSIS; PRIORITY JOURNAL; SIDE EFFECT; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TREATMENT DURATION; TREATMENT RESPONSE; VAGINAL DRYNESS;

ADULT; ALGORITHMS; FEMALE; HUMANS; MENORRHAGIA; THROMBOCYTOPENIA;

EID: 34848889621     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000279138.64895.2b     Document Type: Article

References (15)

1. Ewenstein BM. The pathophysiology of bleeding disorders presenting as abnormal uterine bleeding. Am J Obstet Gynecol1996;175:770-7.
2. Fraser IS, Bonnar J, Peyvandi F. Requirements for research investigations to clarify the relationships and management of menstrual abnormalities in women with hemostatic disorders. Fertil Steril 2005;84:1360-5.
3. Bevan JA, Maloney KW, Hillery CA, Gill JC, Montgomery RR, Scott JP. Bleeding disorders: a common cause of menorrhagia in adolescents. J Pediatr 2001;138:856-61.
4. Meirow D, Rabinovici J, Katz D, Or R, Ben-Yehuda D. Prevention of severe menorrhagia in oncology patients with treatment-induced thrombocytopenia by luteinizing hormone-releasing hormone agonist and depo-medroxyprogesterone acetate. Cancer 2006;107:1634-41.
5. Kadir RA, Economides DL, Sabin CA, Owens D, Lee CA. Frequency of inherited bleeding disorders in women with menorrhagia. Lancet 1998;351:485-9.
6. Dilley A, Drews C, Lally C, Austin H, Barnhart E, Evatt B. A survey of gynecologists concerning menorrhagia: perceptions of bleeding disorders as a possible cause. J Womens Health Gend Based Med 2002;11:39-44.
7. Brown PM, Farquhar CM, Lethaby A, Sadler LC, Johnson NP. Cost-effectiveness analysis of levonorgestrel intrauterine system and thermal balloon ablation for heavy menstrual bleeding. BJOG 2006;113:797-803.
8. Amsterdam A, Jakubowski A, Castro-Malaspina H, Baxi E, Kauff N, Krychman M, et al. Treatment of menorrhagia in women undergoing hematopoietic stem cell transplantation. Bone Marrow Transplant 2004;34:363-6.
9. Laufer MR, Townsend NL, Parsons KE, Brody KA, Diller LR, Emans SJ, et al. Inducing amenorrhea during bone marrow transplantation: a pilot study of leuprolide acetate. J Reprod Med 1997;42:537-41.
10. Roth TM, Rivlin ME. Tuboovarian abscess: a postoperative complication of endometrial ablation. Obstet Gynecol 2004;104:1198-9.
11. Amso NN, Stabinsky SA, McFaul P, Blanc B, Pendley L, Neuwirth R. Uterine thermal balloon therapy for the treatment of menorrhagia: the first 300 patients from a multi-centre study. International Collaborative Uterine Thermal Balloon Working Group. Br J Obstet Gynaecol 1998;105:517-23.
12. Kir M, Hanlon-Lundberg KM. Successful pregnancy after thermal balloon endometrial ablation. Obstet Gynecol 2004;103:1070-3.
13. Livingstone M, Fraser IS. Mechanisms of abnormal uterine bleeding. Hum Reprod Update 2002;8:60-7.
14. Hawiger J. Formation and regulation of platelet and fibrin hemostatic plug. Hum Pathol 1987;18:111-22.
15. Lisman T, Weeterings C, de Groot PG. Platelet aggregation: involvement of thrombin and fibrin(ogen). Front Biosci 2005;10:2504-17.